Columbia Care Continues to Expand Presence in Pennsylvania with Opening of Dispensary in Wilkes-Barre

NEW YORK, Dec. 03, 2018 — Columbia Care LLC (“Columbia Care”), the nation’s leading medical cannabis company, announces the opening of an additional medical cannabis dispensary in Pennsylvania. The new dispensary, located at 765 Kidder Street in Wilkes-Barre, opened today, December 3, 2018. The location is Columbia Care’s second dispensary serving qualifying patients in Pennsylvania, following Read More

Columbia Care Leads US Cannabis Industry Towards Global Expansion By Becoming First American Company Licensed in European Union

Launches EU and global expansion strategy with fully integrated license issued by federal government of Malta NEW YORK – Nov. 15, 2018 – Columbia Care LLC, the leading medical cannabis company in the United States (U.S.), announced today that it received notification that its application for licensure in Malta has been approved by Malta Enterprise, Read More

Columbia Care and The Center for Discovery to Collaborate on Study Examining the Use of Cannabis-Derived Medicines in Treating Epilepsy

Research to be led by neurologist Orrin Devinsky, M.D., director of NYU Langone’s Comprehensive Epilepsy Center and world leader in the study of epilepsy, and Dr. Terry Hamlin, associate executive director of The Center for Discovery, renowned for complex care Study will investigate the optimal dose of Columbia Care’s ClaraCeed™ and ClaraCeed Ultra™ cannabis-derived tablets Read More

Columbia Care Secures Good Manufacturing Practice (GMP) Certification for Medical Cannabis Manufacturing Facility in Florida

Columbia Care Florida achieves GMP certification, reinforcing its commitment to quality and safety in medical cannabis manufacturing Manufacturing facility reports record tolerance specifications of less than 1% active pharmaceutical ingredient (API) variability across initial production batches ARCADIA, FL – Nov. 6, 2018 – Columbia Care LLC, the nation’s leading medical cannabis company, today announced that Read More

Columbia University Receives National Institute on Drug Abuse (NIDA) Research Grant to Study Impact of Medical Cannabis on Opioid Use in Collaboration with Columbia Care

Grant research will build upon Columbia Care’s pilot data demonstrating that 62% of neuropathy patients decreased or stopped opioid use while taking Columbia Care’s dose-metered cannabinoid medicines NEW YORK, Oct. 31, 2018 – The Columbia University Department of Psychiatry and Columbia Care LLC, the nation’s leading medical cannabis company, today announced that researchers from Columbia Read More

Columbia Care Selected by the Virginia Board of Pharmacy as One of Five Licensees to Produce and Dispense Cannabinoid-Based Medicines in Virginia

After highly competitive selection and vetting process, Columbia Care to produce CBD and THC-A oils in Health Service Area V and serve throughout the Commonwealth Full approval would make Virginia the 13th highly regulated state where Columbia Care is licensed to operate NEW YORK, NY Oct. 25, 2018 – Columbia Care LLC (“Columbia Care”), the Read More

Columbia Care Introduces Proprietary, Pharmaceutical-Quality, Long-Lasting Medical Cannabis EleCeed™ Tablets

EleCeed is the nation’s first precisely-dosed medication that combines equal levels of THC and CBD with a balanced portfolio of secondary cannabinoids delivered in a long-lasting pharmaceutical-quality hard-pressed tablet The patent-pending pre-scored tablets are now available in 15- and 30-count bottles to patients throughout New York EleCeed tablets are engineered to address the needs of Read More

Columbia Care Receives Authorization from the Florida Department of Health Office of Medical Marijuana Use to Begin Dispensing Its Cannabis-Based Products

The company is offering home delivery to patients registered with Florida’s Office of Medical Marijuana Use   ARCADIA, FL – July 5, 2018 – Columbia Care LLC, the nation’s leading medical cannabis company, announced that it has been authorized to begin dispensing the company’s pharmaceutical-quality cannabis-based medicines in Florida. The company is now offering home Read More

Columbia Care Appoints Global Bioinformatics and Healthcare Leaders to Scientific Advisory Board

Published on June 25 on GlobeNewswire Carlos D. Bustamante, Ph.D., Professor and Chair of Biomedical Data Science at Stanford University, and Stephen B. Bonner, Former President and CEO of Cancer Treatment Centers of America and Harvard Business School Entrepreneur in Residence, Join Columbia Care NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) — Columbia Care LLC, Read More

Columbia Care, a Vertically Integrated Medical Cannabis Company, Opens Its First Dispensary in Delaware

Columbia Care is the first medical cannabis operator in Delaware to offer pharmaceutical-quality cannabis-based medicines SMYRNA, DE – June 26, 2018 – Columbia Care LLC, the nation’s largest and most experienced medical cannabis company, announced that it will open its first medical cannabis dispensary in Delaware to qualifying patients on Friday, June 29, 2018. The Read More

1 2 3